The different BC subtypes can be distinguished based on the expression level of four significant biomarkers by immunohistochemistry: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67. Here, ERBB2 is linked to breast cancer.